Related Experiment Video
Updated: Sep 8, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Integrated screens uncover a cell surface tumor suppressor gene KIRREL involved in Hippo pathway
1Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract:
Cell surface proteins play essential roles in various biological processes and are highly related to cancer development. They also serve as important markers for cell identity and targets for pharmacological intervention. Despite their great potentials in biomedical research, comprehensive functional analysis of cell surface proteins remains scarce. Here, with a de novo designed library targeting cell surface proteins, we performed in vivo CRISPR screens to evaluate the effects of cell surface proteins on tumor survival and proliferation. We found that Kirrel1 loss markedly promoted tumor growth in vivo. Moreover, KIRREL was significantly enriched in a separate CRISPR screen based on a specific Hippo pathway reporter. Further studies revealed that KIRREL binds directly to SAV1 to activate the Hippo tumor suppressor pathway. Together, our integrated screens reveal a cell surface tumor suppressor involved in the Hippo pathway and highlight the potential of these approaches in biomedical research.
Insights
Loss of cell surface protein Kirre1 (KIRREL) promotes tumor growth by inactivating the Hippo pathway. This study reveals KIRREL as a novel tumor suppressor and highlights CRISPR screening for cell surface protein discovery.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Cell surface proteins are crucial for biological processes and cancer development.
- They are valuable markers for cell identity and drug targets.
- Comprehensive functional analysis of cell surface proteins is limited.
Purpose of the Study:
- To functionally analyze cell surface proteins using in vivo CRISPR screens.
- To identify cell surface proteins affecting tumor survival and proliferation.
- To uncover novel cell surface tumor suppressors and their mechanisms.
Main Methods:
- Designed a de novo library targeting cell surface proteins.
- Performed in vivo CRISPR screens to assess protein function in tumors.
- Utilized a Hippo pathway reporter for enrichment screening.
- Conducted biochemical assays to determine protein interactions.
Main Results:
- Loss of Kirre1 (KIRREL) significantly promoted tumor growth in vivo.
- KIRREL was identified through CRISPR screens targeting the Hippo pathway.
- KIRREL directly binds to SAV1, activating the Hippo tumor suppressor pathway.
Conclusions:
- Kirre1 acts as a cell surface tumor suppressor.
- KIRREL regulates tumor growth via the Hippo pathway.
- CRISPR screening is a powerful approach for cell surface protein discovery in cancer research.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:26Quantitative PCR-based Assay to Measure Sonic Hedgehog Signaling in Cellular Model of Ciliogenesis
Published on: January 31, 2025
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...